High affinity presentation of an autoantigenic peptide in type I diabetes by an HLA class II, protein encoded in a haplotype protecting from disease

Journal of Autoimmunity

Volumn 10, Issue 4, 1997, Pages 375-386

  Bach, Jean Marie ^a   Otto, Heike ^b   Nepom, Gerald T ^c   Jung, Günther ^b   Cohen, Hélène ^a   Timsit, José ^a   Boitard, Christian ^a   Van Endert, Peter M ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

Glutamic acid decarboxylase; HLA class II presentation; Insulin dependent diabetes mellitus; T cell epitopes

Indexed keywords

AUTOANTIGEN; HLA ANTIGEN CLASS 2;

ADULT; ANTIGEN PRESENTATION; ARTICLE; AUTOIMMUNITY; CASE REPORT; DNA POLYMORPHISM; HAPLOTYPE; HUMAN; HUMAN CELL; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE PROLIFERATION; MALE; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0031214615     PISSN: 08968411     EISSN: None     Source Type: Journal    
DOI: 10.1006/jaut.1997.0143     Document Type: Article

References (45)

1. Shizuru J.A., Taylor-Edwards S., Banks A., Gregory K., Fathman G. Treatment with an antibody to T helper lymphocytes. Science. 240:1988;659-662.
2. Boitard C., Bendelac A., Richard M.F., Carnaud C., Bach J.F. Prevention of diabetes in nonobese diabetic mice by anti-I-A monoclonal antibodies: transfer of protection by splenic T cells. Proc. Natl. Acad. Sci. USA. 85:1988;9719-9723.
3. Christianson S.W., Shultz L.D., Leiter E.H. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Diabetes. 42:1993;44-55.
4. Nepom G.T., Erlich H. MHC class-II molecules and autoimmunity. Annu. Rev. Immunol. 9:1991;493-525.
5. Thorsby E., Ronningen K.S. Particular HLA-DQ molecules play a dominant role in determining susceptibility or resistance to type I (insulin-dependent) diabetes mellitus. Diabetologia. 36:1993;371-377.
6. Thomson G., Robinson W.P., Kuhner M.K., Joe S., MacDonald M.J., Gottschall J.L., Barbosa J., Rich S.S., Bertrams J., Baur M.P., Partanen J., Tait B.D., Schober E., Mayr W.R., Ludvigsson J., Lindblom B., Farid N.R., Thompson C., Deschamps I. Genetic heterogeneity, modes of inheritance, and risk estimate for a joint study of Caucasians with insulin-dependent diabetes mellitus. Am. J. Hum. Genet. 43:1988;799-816.
7. Wolf E., Spencer K.M., Cudworth A.G. The genetic susceptibility of type-1 (insulin dependent) diabetes: analysis of the HLA-DR association. Diabetologia. 24:1983;224-230.
8. Thomson G. HLA-DR antigens and susceptibility to insulin-dependent diabetes mellitus. Am. J. Hum. Genet. 36:1984;1309-1317.
9. Caillat-Zucman S., Garchon H.-J., Timsit J., Assan R., Boitard C., Djilali-Saiah I., Bougnères P., Bach J.-F. Age-dependent HLA genetic heterogeneity of type 1 insulin-dependent diabetes mellitus. J. Clin. Invest. 90:1992;2242-2250.
10. Ronningen K.S., Spurkland A., Iwe T., Vartdal F., Thorsby E. Distribution of HLA-DRB1, -DQA1 and -DQB1 alleles and DQA1-DQB1 genotypes among Norwegian patients with insulin-dependent diabetes mellitus. Tissue Antigens. 37:1991;105-111.
11. Cavan D.A., Jacobs K.H., Penny M.A., Kelly M.A., Mijovic C., Jenkins D., Fletcher J.A., Barnett A.H. Both DQA1 and DQB1 genes are implicated in HLA-associated protection from type 1 (insulin-dependent) diabetes mellitus in a British Caucasian population. Diabetologia. 36:1993;252-257.
12. Pugliese A., Gianani R., Moromisato R., Awdeh Z.L., Alper C.A., Erlich H.A., Jackson R.A., Eisenbarth G.S. HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM. Diabetes. 44:1995;608-613.
13. Sheehy M.J., Scharf S.J., Rowe R.J., Neme de Gimenez M.H., Meske L.M., Erlich H.A., Nepom B.S. A diabetes susceptible HLA haplotype is best defined by a combination of HLA-DR and -DQ alleles. J. Clin. Invest. 83:1989;830-835.
14. Erlich H.A., Zeidler A., Chang J., Shaw S., Raffel L.J., Klitz W., Beshkov Y., Costin G., Pressman S., Bugawan T., Rotter J.I. HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families. Nature Genetics. 3:1993;358-364.
15. Cucca F., Lampus R., Frau F., Macis D., Angius E., Masile P., Chessa M., Frongia P., Silvetti M., Cao A., De Virgiliis S., Congia M. The distribution of DR4 haplotypes in Sardinia suggests a primary association of type I diabetes with DRB1 and DQB1 loci. Hum. Immunol. 43:1995;301-308.
16. Sinha A.A., Lopez M.T., McDevitt H.O. Autoimmune diseases: the failure of self tolerance. Science. 248:1990;1380-1388.
17. Healey D., Ozegbe P., Arden S., Chandler P., Hutton J., Cooke A. In vivo activity and in vitro specificity of CD4+ Th1 and Th2 cells derived from the spleen of diabetic NOD mice. J. Clin. Invest. 95:1995;2979-2985.
18. Liblau R.S., Singer S.M., McDevitt H.O. Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases. Immunol. Today. 16:1995;34-38.
19. Katz J.D., Benoist C., Mathis D. T helper cell subsets in insulin-dependent diabetes. Science. 268:1995;1185-1188.
20. Nepom G.T. A unified hypothesis for the complex genetics of HLA associations with IDDM. Diabetes. 39:1990;1153-1157.
21. Sheehy M.J. HLA and insulin-dependent diabetes. A protective perspective. Diabetes. 41:1992;123-129.
22. Baekkeskov S., Aanstoot H.J., Christgau S., Reetz A., Solimena M., Cascalho M., Folli F., Richter-Olesen H., Camilli P.-D. Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase. Nature. 347:1990;151-156.
23. Seissler J., Amann J., Mauch L., Haubruck H., Wolfahrt S., Bieg S., Richter W., Holl R., Heinze E., Northemann W., Scherbaum W.A. Prevalence of autoantibodies to the 65- and 67-kD isoforms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J. Clin. Invest. 92:1993;1394-1399.
24. Petersen J.S., Hejnaes K.R., Moody A., Karlsen A.E., Marshall M.O., Hoier-Madsen M., Boel E., Michelsen B.K., Dyrberg T. Detection of GAD65 antibodies in diabetes and other autoimmune diseases using a simple radioligand assay. Diabetes. 43:1994;459-467.
25. Tisch R., Yand X.-D., Singer S.M., Liblau R.S., Fugger L., McDevitt H.O. Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice. Nature. 366:1993;72-75.
26. Kaufman D.L., Clare-Salzler M., Tian J., Forsthuber T., Ting G.S.P., Robinson P., Atkinson M.A., Sercarz E., Tobin A.J., Lehmann P.V. Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes. Nature. 366:1993;69-72.
27. Atkinson M.A., Kaufman D.L., Campbell L., Gibbs K.A., Shah S., Bu D.-F., Erlander M.G., Tobin A.J., Maclaren N.K. Response of peripheral-blood mononuclear cells to glutamate decarboxylase in insulin-dependent diabetes. Lancet. 339:1992;458-459.
28. Harrison L.C., Honeyman M.C., DeAizpurua H.J., Schmidli R.S., Colman P.G., Tait B.D., Cram D.S. Inverse relation between humoral and cellular immunity to glutamic acid decarboxylase in subjects at risk of insulin-dependent diabetes. Lancet. 341:1993;1365-1369.
29. Worsaae A., Hejnaes K., Moody A., Ludvigsson J., Pociot F., Lorenzen T., Dyrberg T. T cell proliferative responses to glutamic acid decarboxylase-65 in IDDM are negatively associated with HLA DR3/4. Autoimmunity. 22:1995;183-189.
30. Lohmann T., Leslie R.D.G., Hawa M., Geysen M., Rodda S., Londei M. Immunodominant epitopes of glutamic acid decarboxylase 65 and 67 in insulin-dependent diabetes mellitus. Lancet. 343:1994;1607-1608.
31. Atkinson M.A., Bowman M.A., Campbell L., Darrow B.L., Kaufman D.L., Mclaren N.K. Cellular immunity to a determinant common to glutamate decarboxylase and coxsackie virus in insulin-dependent diabetes. J. Clin. Invest. 94:1994;2125-2129.
32. Panina Bordignon P., Lang R., van Endert P., Benazzi E., Felix A., Pastore R., Spinas G., Sinigaglia F. Cytotoxic T cells specific for glutamic acid decarboxylase in autoimmune diabetes. J. Exp. Med. 181:1995;1923-1927.
33. Chang Y.C., Gottlieb D.I. Characterization of the proteins purified with monoclonal antibodies to glutamic acid decarboxylase. J. Neurosci. 8:1988;2123-2130.
34. King D.S., Fields C.G., Fields G.B. A cleavage method which minimizes side reactions following Fmoc solid phase peptide synthesis. Int. J. Pept. Protein Res. 36:1990;255-266.
35. Albericio F., Barany G. An acid-labile anchoring linkage for solid-phase synthesis of C-terminal peptide amides under mild conditions. Int. J. Pept. Protein Res. 30:1987;206-216.
36. Kwok W.W., Nepom G.T., Raymond F.C. HLA-DQ polymorphisms are highly selective for peptide binding interactions. J. Immunol. 155:1995;2468-2476.
37. Kaufman D.L., Erlander M.G., Clare-Salzler M., Atkinson M.A., Maclaren N.K., Tobin A.J. Autoimmunity to two forms of glutamate decarboxylase in insulin-dependent diabetes mellitus. J. Clin. Invest. 98:1992;283-292.
38. Wucherpfennig K.W., Sette A., Southwood S., Oseroff C., Matsui M., Strominger J.L., Hafler D.A. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. J. Exp. Med. 179:1994;279-290.
39. Valli A., Sette A., Kappos L., Oseroff C., Sidney J., Miescher G., Hochberger M., Albert E.D., Adorini L. Binding of myelin basic protein peptides to human histocompatibility leukocyte antigen class II molecules and their recognition by T cells from multiple sclerosis patients. J. Clin. Invest. 91:1993;616-628.
40. Rammensee H.G., Friede T., Stefanoviç S. MHC ligands and peptide binding motifs: first listing. Immunogenetics. 41:1995;178-228.
41. Vogt A.B., Kropshofer H., Kalbacher H., Kalbus M., Rammensee H.G., Coligan J.E., Martin R. Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides. J. Immunol. 153:1994;1665-1673.
42. Erlich H.A., Griffith R.L., Bugawan T.L., Ziegler R., Alper C., Eisenbarth G. Implication of specific DQB1 alleles in genetic susceptibility and resistance by identification of IDDM siblings with a novel HLA-DQB1 allele and unusual DR2 and DR1 haplotypes. Diabetes. 40:1991;478-480.
43. Sterkers G., Zeliszewski D., Chaussée A.M., Deschamps I., Font M.P., Freidel C., Hors J., Betuel H., Dausset J., Levy J.P. HLA-DQ rather than HLA-DR region might be involved in dominant nonsusceptibility to diabetes. Proc. Natl. Acad. Sci. USA. 85:1988;6473-6477.
44. Kwok W.K., Domeier M.E., Raymond F.C., Byers P., Nepom G.T. Allele-specific motifs characterize HLA-DQ interactions with a diabetes-associated peptide derived from glutamic acid decarboxylase. J. Immunol. 156:1996;2171-2177.
45. Tian J., Lehman P.V., Kaufman D.L. T cell cross-reactivity between Coxsackie virus and glutamate decarboxylase is associated with a murine diabetes susceptibility allele. J. Exp. Med. 180:1994;1979-1984.